Lung cancer has long been one of the leading causes of cancer incidence and mortality worldwide. With rapid advances in molecular biology, immunology, and drug development, lung cancer treatment is undergoing a profound transformation. Inā¦
Prostate cancer remains one of the most commonly diagnosed malignancies among men worldwide, and despite significant advances in diagnosis and treatment, disease progression and therapeutic resistance continue to pose major clinical challenges. Ariane (rezvilutamide) asā¦
For patients diagnosed with HR-positive, HER2-negative breast cancer, treatment is often not a single drug but a carefully designed strategy. Among the most important advances in recent years is the introduction of CDK4/6 inhibitors, andā¦
Pulmonary hypertension (PH) is a progressive and potentially life-threatening condition characterized by persistently elevated pressure in the pulmonary circulation. ā ļø Early symptomsāsuch as shortness of breath, fatigue, and reduced exercise toleranceāare often nonspecific, leading toā¦
In China, chronic hepatitis B remains a major public health challenge, affecting tens of millions of people. š For patients who require long-term antiviral therapy, treatment often presents a difficult dilemma: This ongoing treatment journeyā¦
As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to reshape healthcare, the pharmaceutical industry is facing unprecedented opportunities and challenges. As a critical bridge between pharmaceutical innovation and clinicalā¦
In the field of oncology, relapsed or refractory peripheral T-cell lymphoma (PTCL) and endocrine therapy resistance in HR-positive advanced breast cancer remain two major clinical challenges. It is in response to these significant unmet medicalā¦
The treatment of advanced gastrointestinal stromal tumors (GIST) is a long and arduous race against genetic mutations. š Patients typically follow a standard sequential treatment pathway: first-line imatinib, second-line sunitinib, and third-line regorafenib. ā¹ļø However,ā¦
In the field of HIV antiviral therapy, āsimplificationā and āpotencyā have long been the two enduring goals that define the gold standard in HIV treatment. A prime example that perfectly integrates both is BiktarvyĀ®āa single-tabletā¦
When should you take Avatrombopag Maleate (Qinganxin)? ā Platelets, these tiny components in the blood, play a crucial role in the bodyās clotting process. When their numbers drop significantly, the body is left without anā¦
Tumour growth and metastasis are highly dependent on the formation of new blood vessels, a process termed tumour angiogenesis. As conventional treatment strategies face challenges such as tumour resistance and recurrence, interventions targeting angiogenesis haveā¦
In advanced colorectal cancer, the exhaustion of first- and second-line standard chemotherapies and targeted therapies often results in a later-line treatment bottleneck, characterized by renewed disease progression and severely limited therapeutic options. This created anā¦
